<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font22">and </span>
   <span class="font14">for </span>
   <span class="font13">with </span>
   <span class="font13">[]. </span>
   <span class="font12">that </span>
   <span class="font12">COVID- </span>
   <span class="font12">&amp;lt; </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">The </span>
   <span class="font11">are </span>
   <span class="font11">treatment </span>
   <span class="font11">RDV </span>
   <span class="font11">viral </span>
   <span class="font11">was </span>
   <span class="font11">clinical </span>
   <span class="font11">were </span>
   <span class="font11">infection </span>
   <span class="font11">patients </span>
   <span class="font11">antiviral </span>
   <span class="font11">from </span>
   <span class="font11">its </span>
   <span class="font10">this </span>
   <span class="font10">against </span>
   <span class="font10">also </span>
   <span class="font10">virus </span>
   <span class="font10">[,]. </span>
   <span class="font10">such </span>
   <span class="font10">which </span>
   <span class="font10">coronavirus </span>
   <span class="font10">their </span>
   <span class="font10">use </span>
   <span class="font10">RNA </span>
   <span class="font10">but </span>
   <span class="font10">respiratory </span>
   <span class="font10">HCQ </span>
   <span class="font10">days </span>
   <span class="font10">drugs </span>
   <span class="font10">other </span>
   <span class="font10">profile </span>
   <span class="font10">studies </span>
   <span class="font10">{background </span>
   <span class="font10">adverse </span>
   <span class="font10">these </span>
   <span class="font10">not </span>
   <span class="font10">potential </span>
   <span class="font10">severe </span>
   <span class="font10">mechanism </span>
   <span class="font10">online: </span>
   <span class="font10">.collab: </span>
   <span class="font10">data </span>
   <span class="font10">drug </span>
   <span class="font10">effects </span>
   <span class="font10">protein </span>
   <span class="font10">results </span>
   <span class="font10">both </span>
   <span class="font10">can </span>
   <span class="font10">has </span>
   <span class="font10">study </span>
   <span class="font10">host </span>
   <span class="font10">Treatment </span>
   <span class="font10">activity </span>
   <span class="font10">interactions </span>
   <span class="font10">into </span>
   <span class="font10">reported </span>
   <span class="font10">therapy </span>
   <span class="font10">Clinical </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">[], </span>
   <span class="font10">compared </span>
   <span class="font10">human </span>
   <span class="font10">margin </span>
   <span class="font10">recommended </span>
   <span class="font10">should </span>
   <span class="font10">two </span>
   <span class="font10">ADME </span>
   <span class="font10">proteins </span>
   <span class="font10">terms </span>
   <span class="font10">{border-style </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">day </span>
   <span class="font10">group </span>
   <span class="font10">several </span>
   <span class="font10">ACE </span>
   <span class="font10">LPV/r </span>
   <span class="font10">only </span>
   <span class="font10">px;} </span>
   <span class="font10">structure </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">area </span>
   <span class="font10">been </span>
   <span class="font10">between </span>
   <span class="font10">compounds </span>
   <span class="font10">glycoprotein </span>
   <span class="font10">high </span>
   <span class="font10">highlighted </span>
   <span class="font10">increased </span>
   <span class="font10">inflammatory </span>
   <span class="font10">might </span>
   <span class="font10">oral </span>
   <span class="font10">some </span>
   <span class="font10">trials </span>
   <span class="font10">within </span>
   <span class="font10">Severe </span>
   <span class="font10">binding </span>
   <span class="font10">cells </span>
   <span class="font10">considered </span>
   <span class="font10">disease </span>
   <span class="font10">hepatic </span>
   <span class="font10">most </span>
   <span class="font10">safety </span>
   <span class="font10">trial </span>
   <span class="font10">Figure </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">after </span>
   <span class="font10">associated </span>
   <span class="font10">effect </span>
   <span class="font10">following </span>
   <span class="font10">form </span>
   <span class="font10">mg/day </span>
   <span class="font10">protease </span>
   <span class="font10">showed </span>
   <span class="font10">well </span>
   <span class="font10">(Figure </span>
   <span class="font10">(i) </span>
   <span class="font10">April </span>
   <span class="font10">May </span>
   <span class="font10">administration </span>
   <span class="font10">combination </span>
   <span class="font10">days) </span>
   <span class="font10">enzymes </span>
   <span class="font10">ill </span>
   <span class="font10">molecular </span>
   <span class="font10">novel </span>
   <span class="font10">regarding </span>
   <span class="font10">significant </span>
   <span class="font10">therapeutic </span>
   <span class="font10">(ii) </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">This </span>
   <span class="font10">agents </span>
   <span class="font10">basis </span>
   <span class="font10">cell </span>
   <span class="font10">efficacy </span>
   <span class="font10">followed </span>
   <span class="font10">have </span>
   <span class="font10">highly </span>
   <span class="font10">main </span>
   <span class="font10">multiple </span>
   <span class="font10">present </span>
   <span class="font10">release </span>
   <span class="font10">represents </span>
   <span class="font10">spike </span>
   <span class="font10">syndrome </span>
   <span class="font10">under </span>
   <span class="font10">using </span>
   <span class="font10">via </span>
   <span class="font10">whereas </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Patients </span>
   <span class="font10">antibodies </span>
   <span class="font10">authors </span>
   <span class="font10">complex </span>
   <span class="font10">conducted </span>
   <span class="font10">different </span>
   <span class="font10">drugâ€"drug </span>
   <span class="font10">genome </span>
   <span class="font10">infection, </span>
   <span class="font10">inhibitor </span>
   <span class="font10">number </span>
   <span class="font10">possible </span>
   <span class="font10">related </span>
   <span class="font10">vitro </span>
   <span class="font10">when </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Drug </span>
   <span class="font10">Med. </span>
   <span class="font10">RDV, </span>
   <span class="font10">RdRp </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">able </span>
   <span class="font10">based </span>
   <span class="font10">bioavailability </span>
   <span class="font10">compound </span>
   <span class="font10">could </span>
   <span class="font10">early </span>
   <span class="font10">effective </span>
   <span class="font10">events </span>
   <span class="font10">first </span>
   <span class="font10">guidelines </span>
   <span class="font10">important </span>
   <span class="font10">inhibition </span>
   <span class="font10">later </span>
   <span class="font10">new </span>
   <span class="font10">owing </span>
   <span class="font10">performed </span>
   <span class="font10">plasma </span>
   <span class="font10">recent </span>
   <span class="font10">receptor </span>
   <span class="font10">risk </span>
   <span class="font10">used </span>
   <span class="font10">value </span>
   <span class="font10">-day </span>
   <span class="font10">Trial </span>
   <span class="font10">according </span>
   <span class="font10">administered </span>
   <span class="font10">calculated </span>
   <span class="font10">currently </span>
   <span class="font10">cytokine </span>
   <span class="font10">enzyme </span>
   <span class="font10">following: </span>
   <span class="font10">follows: </span>
   <span class="font10">free </span>
   <span class="font10">further </span>
   <span class="font10">interleukin- </span>
   <span class="font10">leading </span>
   <span class="font10">lopinavir </span>
   <span class="font10">order </span>
   <span class="font10">shows </span>
   <span class="font10">side </span>
   <span class="font10">specific </span>
   <span class="font10">structural </span>
   <span class="font10">than </span>
   <span class="font10">(IL-), </span>
   <span class="font10">According </span>
   <span class="font10">Chemical </span>
   <span class="font10">CoVs </span>
   <span class="font10">Infect. </span>
   <span class="font10">SARS </span>
   <span class="font10">about </span>
   <span class="font10">achieved </span>
   <span class="font10">acid </span>
   <span class="font10">active </span>
   <span class="font10">being </span>
   <span class="font10">bonds </span>
   <span class="font10">cells, </span>
   <span class="font10">chloroquine </span>
   <span class="font10">common </span>
   <span class="font10">compassionate </span>
   <span class="font10">convalescent </span>
   <span class="font10">described </span>
   <span class="font10">during </span>
   <span class="font10">green </span>
   <span class="font10">immune </span>
   <span class="font10">mgâ€" </span>
   <span class="font10">monoclonal </span>
   <span class="font10">patients, </span>
   <span class="font10">phase </span>
   <span class="font10">reactions </span>
   <span class="font10">sequence </span>
   <span class="font10">space </span>
   <span class="font10">suitable </span>
   <span class="font10">tool </span>
   <span class="font10">treatment, </span>
   <span class="font10">(ESOL) </span>
   <span class="font10">(flexibility): </span>
   <span class="font10">(iii) </span>
   <span class="font10">(in </span>
   <span class="font10">(insaturation): </span>
   <span class="font10">(insolubility): </span>
   <span class="font10">(lipophility): </span>
   <span class="font10">(polarity): </span>
   <span class="font10">Acute </span>
   <span class="font10">Csp </span>
   <span class="font10">FLEX </span>
   <span class="font10">Fraction </span>
   <span class="font10">INSATU </span>
   <span class="font10">INSOLU </span>
   <span class="font10">June </span>
   <span class="font10">LIPO </span>
   <span class="font10">Log </span>
   <span class="font10">National </span>
   <span class="font10">Novel </span>
   <span class="font10">Num. </span>
   <span class="font10">POLAR </span>
   <span class="font10">SIZE: </span>
   <span class="font10">Society </span>
   <span class="font10">SwissADME; </span>
   <span class="font10">TPSA </span>
   <span class="font10">Therapeutic </span>
   <span class="font10">These </span>
   <span class="font10">XLOGP </span>
   <span class="font10">[,,]. </span>
   <span class="font10">[]; </span>
   <span class="font10">affinity </span>
   <span class="font10">among </span>
   <span class="font10">and, </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">antivirals </span>
   <span class="font10">approved </span>
   <span class="font10">cause </span>
   <span class="font10">covering </span>
   <span class="font10">critically </span>
   <span class="font10">decreased </span>
   <span class="font10">description </span>
   <span class="font10">developed </span>
   <span class="font10">docking </span>
   <span class="font10">efficient </span>
   <span class="font10">expression </span>
   <span class="font10">g/mol </span>
   <span class="font10">g/mol, </span>
   <span class="font10">gastrointestinal </span>
   <span class="font10">heparin </span>
   <span class="font10">higher </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">intervals </span>
   <span class="font10">involved </span>
   <span class="font10">liver </span>
   <span class="font10">located </span>
   <span class="font10">lower </span>
   <span class="font10">lung </span>
   <span class="font10">membrane </span>
   <span class="font10">mg/BD) </span>
   <span class="font10">molecule </span>
   <span class="font10">more </span>
   <span class="font10">nucleoside </span>
   <span class="font10">obtained </span>
   <span class="font10">ongoing </span>
   <span class="font10">overlapped </span>
   <span class="font10">patient </span>
   <span class="font10">pharmacokinetic </span>
   <span class="font10">physicochemical </span>
   <span class="font10">proteins, </span>
   <span class="font10">px; </span>
   <span class="font10">rate </span>
   <span class="font10">red </span>
   <span class="font10">remdesivir </span>
   <span class="font10">replication </span>
   <span class="font10">ribavirin </span>
   <span class="font10">rotatable </span>
   <span class="font10">second </span>
   <span class="font10">severely </span>
   <span class="font10">surface </span>
   <span class="font10">there </span>
   <span class="font10">through </span>
   <span class="font10">vascular </span>
   <span class="font10">viruses </span>
   <span class="font10">web </span>
   <span class="font10">{font-family </span>
   <span class="font10">Ã…, </span>
   <span class="font10">âˆ’. </span>
   <span class="font10">â€" </span>
   <span class="font10">(the </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Disease </span>
   <span class="font10">Even </span>
   <span class="font10">Health </span>
   <span class="font10">March </span>
   <span class="font10">Protein </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Syndrome </span>
   <span class="font10">Table </span>
   <span class="font10">agent </span>
   <span class="font10">al. </span>
   <span class="font10">all </span>
   <span class="font10">anti-COVID- </span>
   <span class="font10">care </span>
   <span class="font10">case </span>
   <span class="font10">cases </span>
   <span class="font10">chain </span>
   <span class="font10">domain </span>
   <span class="font10">effectiveness </span>
   <span class="font10">font-size </span>
   <span class="font10">fusion </span>
   <span class="font10">impact </span>
   <span class="font10">improved </span>
   <span class="font10">infections </span>
   <span class="font10">interim </span>
   <span class="font10">key </span>
   <span class="font10">known </span>
   <span class="font10">large </span>
   <span class="font10">latest </span>
   <span class="font10">lopinavir/ritonavir </span>
   <span class="font10">metabolized </span>
   <span class="font10">mild </span>
   <span class="font10">natural </span>
   <span class="font10">need </span>
   <span class="font10">observed </span>
   <span class="font10">oseltamivir </span>
   <span class="font10">pneumonia </span>
   <span class="font10">previous </span>
   <span class="font10">promising </span>
   <span class="font10">recorded </span>
   <span class="font10">responsible </span>
   <span class="font10">revealed </span>
   <span class="font10">ritonavir </span>
   <span class="font10">similar </span>
   <span class="font10">spread </span>
   <span class="font10">still </span>
   <span class="font10">symptomatology </span>
   <span class="font10">symptoms </span>
   <span class="font10">target </span>
   <span class="font10">though </span>
   <span class="font10">thus </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">(iv) </span>
   <span class="font10">Another </span>
   <span class="font10">Available </span>
   <span class="font10">Clin. </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Ebola </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Organization </span>
   <span class="font10">Review </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">SIMPLE </span>
   <span class="font10">Therefore, </span>
   <span class="font10">ability </span>
   <span class="font10">absence </span>
   <span class="font10">acts </span>
   <span class="font10">analog </span>
   <span class="font10">augmented </span>
   <span class="font10">base </span>
   <span class="font10">betulinic </span>
   <span class="font10">blood </span>
   <span class="font10">cellular </span>
   <span class="font10">characterized </span>
   <span class="font10">concerning </span>
   <span class="font10">contains </span>
   <span class="font10">decrease </span>
   <span class="font10">determined </span>
   <span class="font10">development </span>
   <span class="font10">direct </span>
   <span class="font10">distress </span>
   <span class="font10">double; </span>
   <span class="font10">dysfunction </span>
   <span class="font10">emerged </span>
   <span class="font10">endothelial </span>
   <span class="font10">epithelial </span>
   <span class="font10">even </span>
   <span class="font10">fact </span>
   <span class="font10">factor </span>
   <span class="font10">find </span>
   <span class="font10">forms </span>
   <span class="font10">hepatitis </span>
   <span class="font10">hospitalized </span>
   <span class="font10">including </span>
   <span class="font10">infectious </span>
   <span class="font10">information </span>
   <span class="font10">inhibitors </span>
   <span class="font10">interval </span>
   <span class="font10">intracellular </span>
   <span class="font10">mg/dayâ€"day </span>
   <span class="font10">mg/diagnosis; </span>
   <span class="font10">mild-to-moderate </span>
   <span class="font10">newly </span>
   <span class="font10">pathology </span>
   <span class="font10">potent </span>
   <span class="font10">presence </span>
   <span class="font10">present, </span>
   <span class="font10">presents </span>
   <span class="font10">process </span>
   <span class="font10">prolongation </span>
   <span class="font10">proved </span>
   <span class="font10">published </span>
   <span class="font10">receptors </span>
   <span class="font10">relevant </span>
   <span class="font10">renal </span>
   <span class="font10">role </span>
   <span class="font10">serum </span>
   <span class="font10">short </span>
   <span class="font10">small </span>
   <span class="font10">standard </span>
   <span class="font10">structure, </span>
   <span class="font10">they </span>
   <span class="font10">toxicity </span>
   <span class="font10">tract </span>
   <span class="font10">until </span>
   <span class="font10">values </span>
   <span class="font10">various </span>
   <span class="font10">versus </span>
   <span class="font10">virus, </span>
   <span class="font10">will </span>
   <span class="font10">ÂµM </span>
   <span class="font10">(for </span>
   <span class="font10">(which </span>
   <span class="font10">.Van </span>
   <span class="font10">ATP </span>
   <span class="font10">Antimicrob. </span>
   <span class="font10">Arbidol </span>
   <span class="font10">Belgium </span>
   <span class="font10">Betulinic </span>
   <span class="font10">COVID-Available </span>
   <span class="font10">CYPA </span>
   <span class="font10">Chinese </span>
   <span class="font10">Data </span>
   <span class="font10">Drugs </span>
   <span class="font10">European </span>
   <span class="font10">From </span>
   <span class="font10">Given </span>
   <span class="font10">However, </span>
   <span class="font10">Human </span>
   <span class="font10">IL- </span>
   <span class="font10">Infection </span>
   <span class="font10">Infectious </span>
   <span class="font10">MERS-CoV, </span>
   <span class="font10">Mechanism </span>
   <span class="font10">Medicine </span>
   <span class="font10">Mol. </span>
   <span class="font10">Other </span>
   <span class="font10">Pharmacol. </span>
   <span class="font10">Phase </span>
   <span class="font10">Potential </span>
   <span class="font10">RDV-treated </span>
   <span class="font10">Sciences, </span>
   <span class="font10">Their </span>
   <span class="font10">WHO </span>
   <span class="font10">absorption </span>
   <span class="font10">almost </span>
   <span class="font10">amino </span>
   <span class="font10">anti-SARS-CoV- </span>
   <span class="font10">available </span>
   <span class="font10">because </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">children </span>
   <span class="font10">classes </span>
   <span class="font10">coagulation </span>
   <span class="font10">concentrations </span>
   <span class="font10">confirmed </span>
   <span class="font10">consisting </span>
   <span class="font10">control </span>
   <span class="font10">death </span>
   <span class="font10">derivatives </span>
   <span class="font10">diarrhea </span>
   <span class="font10">differences </span>
   <span class="font10">directly </span>
   <span class="font10">does </span>
   <span class="font10">doses </span>
   <span class="font10">effects. </span>
   <span class="font10">entry </span>
   <span class="font10">evaluated </span>
   <span class="font10">evidence </span>
   <span class="font10">excretion </span>
   <span class="font10">favipiravir </span>
   <span class="font10">genomic </span>
   <span class="font10">great </span>
   <span class="font10">included </span>
   <span class="font10">indicate </span>
   <span class="font10">induced </span>
   <span class="font10">inhibitors, </span>
   <span class="font10">injury </span>
   <span class="font10">injury, </span>
   <span class="font10">interaction </span>
   <span class="font10">major </span>
   <span class="font10">may </span>
   <span class="font10">mechanisms </span>
   <span class="font10">medication </span>
   <span class="font10">mg) </span>
   <span class="font10">mortality </span>
   <span class="font10">nausea, </span>
   <span class="font10">pandemic </span>
   <span class="font10">patients), </span>
   <span class="font10">pharmacological </span>
   <span class="font10">phosphate </span>
   <span class="font10">pro-inflammatory </span>
   <span class="font10">prodrug </span>
   <span class="font10">provided </span>
   <span class="font10">reduced </span>
   <span class="font10">required </span>
   <span class="font10">response </span>
   <span class="font10">responses </span>
   <span class="font10">same </span>
   <span class="font10">significantly </span>
   <span class="font10">solid; </span>
   <span class="font10">stage </span>
   <span class="font10">stated </span>
   <span class="font10">symptomatic </span>
   <span class="font10">syndrome, </span>
   <span class="font10">tested </span>
   <span class="font10">those </span>
   <span class="font10">three </span>
   <span class="font10">thrombotic </span>
   <span class="font10">time </span>
   <span class="font10">tissue </span>
   <span class="font10">toxicological </span>
   <span class="font10">transmission </span>
   <span class="font10">triphosphate </span>
   <span class="font10">virions </span>
   <span class="font10">viruses, </span>
   <span class="font10">weight </span>
   <span class="font10">while </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(e.g., </span>
   <span class="font10">(high </span>
   <span class="font10">(most </span>
   <span class="font10">(v) </span>
   <span class="font10">(â€" </span>
   <span class="font10">Acid </span>
   <span class="font10">Allergy </span>
   <span class="font10">Attribution </span>
   <span class="font10">Based </span>
   <span class="font10">China </span>
   <span class="font10">Commons </span>
   <span class="font10">Creative </span>
   <span class="font10">Current </span>
   <span class="font10">Discovery </span>
   <span class="font10">Diseases </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Gilead </span>
   <span class="font10">Heart </span>
   <span class="font10">Insights </span>
   <span class="font10">Monitoring </span>
   <span class="font10">NCT, </span>
   <span class="font10">Oseltamivir </span>
   <span class="font10">Previous </span>
   <span class="font10">RNA-dependent </span>
   <span class="font10">Recent </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">Spike </span>
   <span class="font10">Structurally, </span>
   <span class="font10">Use </span>
   <span class="font10">Viral </span>
   <span class="font10">Virus </span>
   <span class="font10">World </span>
   <span class="font10">[,,,]. </span>
   <span class="font10">accessory </span>
   <span class="font10">addition, </span>
   <span class="font10">additional </span>
   <span class="font10">already </span>
   <span class="font10">although </span>
   <span class="font10">analogue </span>
   <span class="font10">analyses </span>
   <span class="font10">analysis </span>
   <span class="font10">antibody </span>
   <span class="font10">anticoagulant </span>
   <span class="font10">article </span>
   <span class="font10">assembly </span>
   <span class="font10">assessed </span>
   <span class="font10">association </span>
   <span class="font10">azithromycin </span>
   <span class="font10">bold </span>
   <span class="font10">brief </span>
   <span class="font10">choice </span>
   <span class="font10">co-administered </span>
   <span class="font10">concluded </span>
   <span class="font10">confirm </span>
   <span class="font10">considerable </span>
   <span class="font10">consideration </span>
   <span class="font10">correlated </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">date, </span>
   <span class="font10">described, </span>
   <span class="font10">diagnostic </span>
   <span class="font10">diarrhea, </span>
   <span class="font10">disorders </span>
   <span class="font10">disorders, </span>
   <span class="font10">duration </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">encode </span>
   <span class="font10">end </span>
   <span class="font10">evaluate </span>
   <span class="font10">experimental </span>
   <span class="font10">expressed </span>
   <span class="font10">failure, </span>
   <span class="font10">fatal </span>
   <span class="font10">four </span>
   <span class="font10">genes </span>
   <span class="font10">growth </span>
   <span class="font10">health </span>
   <span class="font10">hydrogen </span>
   <span class="font10">hydrophobic </span>
   <span class="font10">hydroxyl </span>
   <span class="font10">immunization </span>
   <span class="font10">impairment, </span>
   <span class="font10">increase </span>
   <span class="font10">induce </span>
   <span class="font10">inflammation </span>
   <span class="font10">influenza </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibiting </span>
   <span class="font10">interactions, </span>
   <span class="font10">invasive </span>
   <span class="font10">is, </span>
   <span class="font10">last </span>
   <span class="font10">lead </span>
   <span class="font10">light </span>
   <span class="font10">long </span>
   <span class="font10">mainly </span>
   <span class="font10">manufacturer </span>
   <span class="font10">mentioned </span>
   <span class="font10">mg; </span>
   <span class="font10">moderate </span>
   <span class="font10">noticed </span>
   <span class="font10">nucleocapsid </span>
   <span class="font10">nucleotide </span>
   <span class="font10">occurs </span>
   <span class="font10">one </span>
   <span class="font10">out </span>
   <span class="font10">outbreak </span>
   <span class="font10">outcome </span>
   <span class="font10">pain, </span>
   <span class="font10">patients. </span>
   <span class="font10">patients; </span>
   <span class="font10">polymerase </span>
   <span class="font10">porcine </span>
   <span class="font10">positive </span>
   <span class="font10">predominantly </span>
   <span class="font10">preliminary </span>
   <span class="font10">presented </span>
   <span class="font10">prevent </span>
   <span class="font10">profile, </span>
   <span class="font10">progress </span>
   <span class="font10">properties </span>
   <span class="font10">prophylaxis </span>
   <span class="font10">protection </span>
   <span class="font10">pt;} </span>
   <span class="font10">pulmonary </span>
   <span class="font10">randomized, </span>
   <span class="font10">recognition </span>
   <span class="font10">report </span>
   <span class="font10">represented </span>
   <span class="font10">repurposed </span>
   <span class="font10">research </span>
   <span class="font10">resolution </span>
   <span class="font10">see </span>
   <span class="font10">show </span>
   <span class="font10">shown </span>
   <span class="font10">sponsored </span>
   <span class="font10">stages </span>
   <span class="font10">status </span>
   <span class="font10">stronger </span>
   <span class="font10">studies, </span>
   <span class="font10">study, </span>
   <span class="font10">suggesting </span>
   <span class="font10">symptom </span>
   <span class="font10">that, </span>
   <span class="font10">tocilizumab </span>
   <span class="font10">transmission, </span>
   <span class="font10">treated </span>
   <span class="font10">unfractionated </span>
   <span class="font10">vaccine </span>
   <span class="font10">vivo </span>
   <span class="font10">where </span>
  </p>
 </body>
</html>
